[1]
“Correlation of the Interlukein-8 with Breast Cancer Patients in Iraqi Woman’s”, Journal of Pharmaceutical Negative Results, pp. 1247–1252, Oct. 2022, doi: 10.47750/pnr.2022.13.S06.164.